Solomon, S. et al. (2004) Effect of candesartan on cause-specific mortality in heart failure patients - The Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation, 110, pp. 2180-2183. (doi: 10.1161/01.CIR.0000144474.65922.AA)
Full text not currently available from Enlighten.
Item Type: | Articles |
---|---|
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | McMurray, Professor John |
Authors: | Solomon, S., Wang, D., Finn, P., Skali, H., Zornoff, L., McMurray, J., Swedberg, K., Yusuf, S., Granger, C., Michelson, E., Pocock, S., and Pfeffer, M. |
College/School: | College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health College of Medical Veterinary and Life Sciences |
Journal Name: | Circulation |
University Staff: Request a correction | Enlighten Editors: Update this record